HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jim Dimitroulakos Selected Research
Jim Dimitroulakos Research Topics
Disease
23
Neoplasms (Cancer)
11/2018 - 07/2002
10
Squamous Cell Carcinoma of Head and Neck
12/2018 - 07/2002
8
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018 - 07/2002
6
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016 - 03/2005
5
Breast Neoplasms (Breast Cancer)
08/2018 - 02/2009
5
Carcinoma (Carcinomatosis)
01/2014 - 07/2002
4
Triple Negative Breast Neoplasms
08/2020 - 12/2016
3
Ovarian Neoplasms (Ovarian Cancer)
08/2020 - 02/2009
2
Lung Neoplasms (Lung Cancer)
02/2019 - 01/2016
2
Carcinogenesis
01/2018 - 01/2018
1
Hypoxia (Hypoxemia)
08/2020
1
Lymphangioleiomyomatosis (Lymphangiomyomatosis)
02/2019
1
Lung Diseases (Lung Disease)
02/2019
1
Tuberous Sclerosis (Bourneville's Disease)
02/2019
1
Oropharyngeal Neoplasms
01/2019
1
Acute Coronary Syndrome
11/2016
1
Septic Shock (Toxic Shock Syndrome)
11/2016
1
Coronary Artery Disease (Coronary Atherosclerosis)
11/2016
1
Pulmonary Arterial Hypertension
11/2016
1
Prostatic Neoplasms (Prostate Cancer)
01/2013
1
Vesicular Stomatitis
08/2012
1
Colorectal Neoplasms (Colorectal Cancer)
02/2012
1
Neoplasm Metastasis (Metastasis)
02/2012
1
Neuroblastoma
12/2010
1
Embryonal Carcinoma
12/2010
1
Mesothelioma
09/2010
1
Malignant Mesothelioma
09/2010
1
Glioblastoma (Glioblastoma Multiforme)
10/2008
1
Adenocarcinoma
11/2003
Drug/Important Bio-Agent (IBA)
11
Lovastatin (Mevacor)
FDA Link
Generic
01/2014 - 07/2002
6
Cisplatin (Platino)
FDA Link
Generic
08/2020 - 07/2010
5
Gefitinib (Iressa)
FDA Link
08/2020 - 03/2005
5
Erlotinib Hydrochloride (CP 358,774)
FDA Link
03/2016 - 07/2006
4
Proteins (Proteins, Gene)
FDA Link
01/2018 - 02/2009
4
ErbB Receptors (EGF Receptor)
IBA
01/2016 - 11/2003
4
Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)
IBA
11/2014 - 07/2002
3
Metformin (Glucophage)
FDA Link
Generic
08/2020 - 01/2012
3
Biomarkers (Surrogate Marker)
IBA
11/2018 - 11/2015
3
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2018 - 10/2008
3
Messenger RNA (mRNA)
IBA
01/2014 - 09/2010
3
Mevalonic Acid (Mevalonate)
IBA
01/2014 - 07/2002
2
Mechanistic Target of Rapamycin Complex 1
IBA
02/2019 - 01/2018
2
Phosphotransferases (Kinase)
IBA
02/2019 - 10/2008
2
Transcription Factors (Transcription Factor)
IBA
08/2018 - 10/2007
2
Activating Transcription Factor 3
IBA
08/2018 - 01/2016
2
DNA (Deoxyribonucleic Acid)
IBA
08/2017 - 01/2017
2
RNA (Ribonucleic Acid)
IBA
11/2016 - 01/2016
2
Rosuvastatin Calcium (Crestor)
FDA Link
03/2016 - 07/2006
2
MicroRNAs (MicroRNA)
IBA
01/2013 - 02/2012
2
Platinum
IBA
08/2011 - 02/2009
2
Vorinostat
FDA Link
08/2011 - 09/2010
2
Histone Deacetylase Inhibitors
IBA
08/2011 - 09/2010
2
Tyrosine Kinase Inhibitors
IBA
03/2005 - 11/2003
1
TOR Serine-Threonine Kinases
IBA
02/2019
1
lipoarabinomannan (LAM)
IBA
02/2019
1
Hydrogels
IBA
02/2019
1
C-Reactive Protein
IBA
01/2019
1
Doxorubicin (Adriamycin)
FDA Link
Generic
08/2018
1
Anthracyclines
IBA
08/2018
1
ICG 001
IBA
01/2018
1
Catenins
IBA
01/2018
1
Sirolimus (Rapamycin)
FDA Link
01/2018
1
Phenobarbital (Luminal)
FDA Link
01/2018
1
Valproic Acid (Depakote)
FDA Link
Generic
01/2018
1
Simvastatin (Zocor)
FDA Link
Generic
01/2018
1
Tamoxifen
FDA Link
Generic
01/2018
1
Viral Oncogene Proteins
IBA
10/2017
1
Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)
IBA
08/2017
1
Progesterone Receptors (Progesterone Receptor)
IBA
12/2016
1
Estrogen Receptor alpha
IBA
12/2016
1
Histone Deacetylases (Histone Deacetylase)
IBA
12/2016
1
Long Noncoding RNA
IBA
11/2016
1
Focal Adhesion Protein-Tyrosine Kinases
IBA
01/2016
1
Cyclin-Dependent Kinase 6
IBA
11/2015
1
Aldosterone
IBA
11/2015
1
cediranib (AZD2171)
IBA
11/2015
1
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
IBA
11/2015
1
Anti-Bacterial Agents (Antibiotics)
IBA
11/2014
1
Monensin (Coban)
IBA
11/2014
1
Interferons
IBA
08/2012
1
Paraffin
IBA
02/2012
1
BRCA1 Protein
IBA
08/2011
1
Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)
IBA
12/2010
1
GAP-43 Protein (GAP 43 Protein)
IBA
12/2010
1
Differentiation Antigens
IBA
12/2010
1
Bucladesine
IBA
12/2010
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
09/2010
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
09/2010
1
Ligands
IBA
09/2010
1
Small Interfering RNA (siRNA)
IBA
07/2010
1
Carboplatin (JM8)
FDA Link
Generic
07/2010
1
epidermal growth factor receptor VIII
IBA
10/2008
1
Adenosine Triphosphate (ATP)
IBA
03/2005
Therapy/Procedure
7
Therapeutics
08/2020 - 11/2003
3
Drug Therapy (Chemotherapy)
08/2018 - 08/2011
1
Transplantation
01/2018
1
Aftercare (After-Treatment)
01/2018
1
Immunotherapy
10/2017
1
Combination Drug Therapy (Combination Chemotherapy)
01/2016
1
Oncolytic Virotherapy
08/2012